ILEX Medical Ltd. (IL:ILX)
TASE:ILX
Total Valuation
Ilex Medical has a market cap or net worth of ₪672.63M. The enterprise value is 543.75M.
Market Cap₪672.63M
Enterprise Value543.75M
Share Statistics
Ilex Medical has 11,188,107 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding11,188,107
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ilex Medical’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.58%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)5.58%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee5.23M
Profits Per Employee416.49K
Employee Count178
Asset Turnover0.94
Inventory Turnover3.70
Valuation Ratios
The current PE Ratio of Ilex Medical is 13.5. Ilex Medical’s PEG ratio is 0.32.
PE Ratio13.5
PS Ratio0.80
PB Ratio1.09
Price to Fair Value1.09
Price to FCF17.46
Price to Operating Cash Flow9.25
PEG Ratio0.32
Income Statement
In the last 12 months, Ilex Medical had revenue of 930.83M and earned 55.55M in profits. Earnings per share was 4.95.
Revenue930.83M
Gross Profit211.88M
Operating Income55.95M
Pretax Income74.14M
Net Income55.55M
EBITDA125.83M
Earnings Per Share (EPS)4.95
Cash Flow
In the last 12 months, operating cash flow was 72.87M and capital expenditures -30.06M, giving a free cash flow of 42.81M billion.
Operating Cash Flow72.87M
Free Cash Flow42.81M
Free Cash Flow per Share3.83
Dividends & Yields
Ilex Medical pays an annual dividend of 121.95, resulting in a dividend yield of 1.79%
Dividend Per Share121.95
Dividend Yield1.79%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.28
52-Week Price Change3.60%
50-Day Moving Average6.04K
200-Day Moving Average6.30K
Relative Strength Index (RSI)51.91
Average Volume (3m)1.86K
Important Dates
Ilex Medical upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Ilex Medical as a current ratio of 2.83, with Debt / Equity ratio of 6.81%
Current Ratio2.83
Quick Ratio2.07
Debt to Market Cap0.00
Net Debt to EBITDA-1.03
Interest Coverage Ratio25.49
Taxes
In the past 12 months, Ilex Medical has paid 18.58M in taxes.
Income Tax18.58M
Effective Tax Rate0.25
Enterprise Valuation
Ilex Medical EV to EBITDA ratio is 4.91, with an EV/FCF ratio of 14.45.
EV to Sales0.66
EV to EBITDA4.91
EV to Free Cash Flow14.45
EV to Operating Cash Flow8.49
Balance Sheet
Ilex Medical has ₪231.64M in cash and marketable securities with ₪46.60M in debt, giving a net cash position of ₪185.04M billion.
Cash & Marketable Securities₪231.64M
Total Debt₪46.60M
Net Cash₪185.04M
Net Cash Per Share₪16.54
Tangible Book Value Per Share₪59.38
Margins
Gross margin is 22.76%, with operating margin of 6.01%, and net profit margin of 5.97%.
Gross Margin22.76%
Operating Margin6.01%
Pretax Margin7.96%
Net Profit Margin5.97%
EBITDA Margin13.52%
EBIT Margin8.20%
Analyst Forecast
The average price target for Ilex Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―